News | Robotic Systems | May 28, 2020

Hoag Performs First Robotic Carotid Artery Stenting on West Coast

Robotic surgery makes carotid stent placement safer and more precise 

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an innovative robotic interventional procedure to stent a blockage in the carotid artery and improving blood flow to the brain. 

Christopher Baker, M.D., performs a robotically navigated carotid stenting procedure at  Hoag Memorial Hospital Presbyterian using a Corindus Corpath robotic system.Christopher Baker, M.D., director of interventional neuroradiology at the Pickup Family Neurosciences Institute at Hoag, implanted the stent using a new robotic tool, the CorPath GRX from Corindus, a Siemens Healthineers company. The robot helps physicians guide a wire, stent and balloon through a small incision in the patient’s arm or leg, and up into the patient’s neck artery to place the stent precisely at the site of blockage. This exact placement of the stent also allows less exposure to radiation for both the patient and the physician.

“CorPath is remarkable because I am able to perform a high precision, complex surgery while not being next to the patient,” Baker said. “The use of this technology means a safer, more precise surgery for the patient.”  

Thanks to donor support, Hoag’s Pickup Family Neurosciences Institute is the first site on the West Coast to perform robotic-assisted carotid stenting. Currently, robots are only FDA cleared for use in certain general surgery procedures and in peripheral vascular and interventional cardiology procedures. Baker said the tool will likely also prove invaluable in neuro-endovascular procedures. “Carotid stenting has been around for many years, but the really exciting part is the new ability to improve patient safety through precise control of the micro-tools we use in the arteries supplying the patient’s brain.”
 
As a founding member of Orange County’s designated Comprehensive Stroke Receiving Centers, Hoag’s Neurosciences team helped pioneer many of the advanced processes and specialized methods to optimize outcomes for stroke patients including prevention and reversal of acute stroke.
 
Hoag has also been designated a Center of Excellence in Robotic Surgery (COERS) by the Surgical Review Corp., which recognizes hospitals and surgeons who demonstrate an exceptional commitment and ability to consistently deliver safe, effective, evidence-based care through robotic surgery. 
 
“We are excited to be one of the first to offer this innovative robotic tool to help treat patients with significant carotid artery stenosis,” Baker said. “One cannot overstate how precision robotic-assisted tools improve outcomes and speed recovery for patients undergoing complex, very delicate surgeries and help us save more lives.”     

Related Cardiology Robotic System Content:

VIDEO: Standardizing PCI Through Smart Robotic Procedural Automation

First-in-Human Telerobotic Coronary Intervention Procedures Published in EClinicalMedicine

Robocath Successfully Carries Out First Robotic Coronary Angioplasties in Humans

Corindus Vascular Robotics to Be Acquired by Siemens Healthineers

Corindus CorPath GRX Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

 

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health

Reducing Physician Radiation Dose With Robotics

Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System

Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention

 

Robots in the Cath Lab

VIDEO: First Robotic PCI Case in Germany With Robocath R-One System

Find more information on robotic systems for the cath and EP labs

Related Content

Videos | Cath Lab | April 02, 2021
Corindus, a Siemens Healthineers company and a developer of vascular robotics, recently launched a new set of automat
Videos | Cath Lab | March 31, 2021
This is a quick example of clinical use of the Shockwave Medical Intravascular Lithotripsy system that uses sonic wav

SpectraWave is developing a a new intravascular imaging system that combines two currently available modalities. This likely includes optical coherence tomography (OCT), left, which can define structures within the vessel and vessel wall.  Near infrared spectroscopy (NIRS), right, enables a spectral chemical analysis of the vessel walls to show areas of high lipid content, and specifically can identify lipid-core plaques that are associated with heart attack-causing plaque ruptures.

News | Cath Lab | February 16, 2021
February 16, 2021 – SpectraWave Inc.
Videos | Cath Lab | February 04, 2021
Cindy Grines, M.D., MSCAI, FACC, president
Among high-risk, chronic, coronary patients who undergo angioplasty, there were no additional benefits from ticagrelor compared to the current standard of care clopidogrel. #AHA #AHA20 #AHA2020
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to clop
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar